Amy Finkelstein is one of the leading applied economists of her generation. Her research focuses primarily on health economics and public economics. She has made fundamental contributions to the empirical analysis of insurance markets and more broadly to the use of randomised controlled trials (RCTs) to assess the impact of public policies. She played a central role in analysing the Oregon Health Insurance Experiment, when access to government-provided Medicaid insurance was rationed by lottery. Beyond her research contributions, she has been an active provider of professional public goods, including as a dissertation supervisor, as the founding editor of the American Economic Review: Insights and as a co-founder of J-PAL North America, a research organisation devoted to advancing the use of RCTs in public policy evaluation.